Monoclonal gammopathy of undetermined significance

TH Mouhieddine, LD Weeks… - Blood, The Journal of …, 2019 - ashpublications.org
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma
cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1% risk of …

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases

K Hemminki, A Försti, R Houlston… - International journal of …, 2021 - Wiley Online Library
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …

Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies

M Bonifazi, F Bravi, S Gasparini, C La Vecchia… - Chest, 2015 - Elsevier
BACKGROUND An increased cancer risk in patients with sarcoidosis has been suggested,
although results are conflicting in a number of case-control and cohort studies. We …

Sepsis and cancer: an interplay of friends and foes

A Mirouse, C Vigneron, JF Llitjos… - American journal of …, 2020 - atsjournals.org
Sepsis and cancer share a number of pathophysiological features, and both result from the
inability of the host's immune system to cope with the initial insult (tissue invasion by …

Monoclonal gammopathy of undetermined significance

WI Gonsalves, SV Rajkumar - Annals of internal medicine, 2022 - acpjournals.org
Monoclonal gammopathy of undetermined significance (MGUS) is of considerable clinical
importance to primary care physicians given its high prevalence in the general population …

The cellular origin and malignant transformation of Waldenström macroglobulinemia

B Paiva, LA Corchete, MB Vidriales… - Blood, The Journal …, 2015 - ashpublications.org
Although information about the molecular pathogenesis of Waldenström macroglobulinemia
(WM) has significantly advanced, the precise cell of origin and the mechanisms behind WM …

[HTML][HTML] Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population …

AÝ Sigurbergsdóttir, S Rögnvaldsson… - …, 2023 - ncbi.nlm.nih.gov
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic
precursor condition that precedes multiple myeloma and related disorders but has also been …

Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study

M Thordardottir, EK Lindqvist, SH Lund… - Blood …, 2017 - ashpublications.org
All multiple myeloma (MM) cases are preceded by the premalignant state monoclonal
gammopathy of undetermined significance (MGUS). Results from previous studies show a …

[HTML][HTML] Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance

A Shimanovsky, AJ Alvarez, S Murali, CA Dasanu - BBA clinical, 2016 - Elsevier
Background Multiple myeloma (MM) and its precursor, monoclonal gammopathy of
undetermined significance (MGUS), have been linked with several autoimmune conditions …

Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review

CM McShane, LJ Murray, O Landgren… - … , biomarkers & prevention, 2014 - AACR
Background: Several observational studies have investigated autoimmune disease and
subsequent risk of monoclonal gammopathy of undetermined significance (MGUS) and …